Niccolo Bertini
Florence, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
SBRT plus abiraterone acetate and ADT versus abiraterone acetate and ADT in oligometastatic castrate-resistant prostate cancer (ARTO): long-term, unplanned overall survival analysis of an open-label, randomised, phase 2 trial.
Journal: The Lancet. Oncology
Published: February 17, 2026
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial.
Journal: BJU international
Published: December 15, 2025
Concomitant radiation therapy and trastuzumab deruxtecan in metastatic breast cancer: feasibility, safety, and outcomes from a real-life multicentre international cohort.
Journal: Breast (Edinburgh, Scotland)
Published: November 07, 2025
Cardiac safety of ultra-hypofractionated whole breast irradiation: Results from the SAFE-FORWARD observational prospective cohort study.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: September 13, 2025
Photon-counting detector computing tomography in treatment planning of head-and-neck cancer.
Journal: Physics and imaging in radiation oncology
Published: August 21, 2025
Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.
Journal: The oncologist
Published: June 13, 2025
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer.
Journal: Expert review of anticancer therapy
Published: May 21, 2025
Re-irradiation in patients affected by prostate cancer and relapsing after previous definitive or postoperative radiotherapy. An international registry based study on behalf of Italian association of radiotherapy and clinical oncology (AIRO). (RE-START).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 20, 2025
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914).
Journal: La Radiologia medica
Published: April 08, 2025
First implementation of photon-counting dector computed tomography for optimizing segmentation in head-and-neck cancer radiotherapy.
Journal: Physics and imaging in radiation oncology
Published: January 20, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719).
Journal: Prostate cancer and prostatic diseases
Published: November 28, 2024
Last Updated: 09/26/2026